Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | CA12 | O43570 | 2/20 | 0.57 |
| ▸ | CA9 | Q16790 | 2/20 | 0.57 |
| ▸ | BRD4 | O60885 | 1/20 | 0.57 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.57 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.57 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.57 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.57 |
| ▸ | CDK4 | P11802 | 4/20 | 0.45 |
| ▸ | CCND1 | P24385 | 4/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | DAO | P14920 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | GPR3 | P46089 | 1/20 | 0.41 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL865039 | 0.73 | ALDH1A1 (0.57) | MAPTALDH1A1CA12CA9BRD4 | |
| SCHEMBL4097687 | 0.73 | CA12 (0.57) | MAPTALDH1A1CA12CA9BRD4 | |
| SCHEMBL248619 | 0.73 | BRPF1 (1.00) | MAPTALDH1A1CA12CA9BRD4 | |
| SCHEMBL29967380 | 0.73 | BRPF1 (1.00) | MAPTALDH1A1CA12CA9BRD4 | |
| Hydrochloric Acid SCHEMBL30419636 | 0.71 | BRPF1 (0.96) | MAPTALDH1A1CA12CA9BRD4 | |
| Hydrochloric Acid SCHEMBL1236989 | 0.71 | BRPF1 (0.96) | MAPTALDH1A1CA12CA9BRD4 | |
| SCHEMBL11549772 | 0.71 | MAPT (0.65) | MAPTALDH1A1BRPF1RXFP1CDK4 | |
| SCHEMBL19669320 | 0.70 | ALDH1A1 (0.54) | MAPTALDH1A1CA12CA9BRD4 | |
| SCHEMBL11377592 | 0.70 | ALDH1A1 (0.53) | MAPTALDH1A1RXFP1KMT2AMCL1 | |
| Hydrochloric Acid SCHEMBL7218030 | 0.70 | BRPF1 (0.92) | MAPTALDH1A1CA12CA9BRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5738969-A | WATER INSOLUBLE COMPOUND HAVING MERCAPTO OR THIONE GROUP, AND SULFONATED STYRENE-CONTAINING POLYMER | MITSUBISHI PAPER MILLS LIMITED (JP) | 1998-04-14 | — | — | US | claimed |
| US-11046889-B2 | Polymerizable compound and optically anisotropic body | DIC CORPORATION (JP) | 2021-06-29 | — | — | US | disclosed |
| US-10919870-B2 | Polymerizable compound and optically anisotropic body | DIC CORPORATION (JP) | 2021-02-16 | — | — | US | disclosed |
| US-10649124-B2 | Composition including compound having mesogenic group, polymer and optically anisotropic body obtained by polymerizing polymerizable composition, and phase difference film | DIC CORPORATION (JP) | 2020-05-12 | — | — | US | disclosed |
| US-20190025490-A1 | COMPOSITION INCLUDING COMPOUND HAVING MESOGENIC GROUP, POLYMER AND OPTICALLY ANISOTROPIC BODY OBTAINED BY POLYMERIZING POLYMERIZABLE COMPOSITION, AND PHASE DIFFERENCE FILM | DIC CORPORATION (JP) | 2019-01-24 | — | — | US | disclosed |
| EP-3346304-A1 | COMPOSITION INCLUDING COMPOUND HAVING MESOGENIC GROUP, POLYMER AND OPTICALLY ANISOTROPIC BODY OBTAINED BY POLYMERIZING POLYMERIZABLE COMPOSITION, AND PHASE DIFFERENCE FILM | DIC Corporation (JP) | 2018-07-11 | — | — | EP | disclosed |
| US-20180022716-A1 | POLYMERIZABLE COMPOUND AND OPTICAL ISOMER | DIC CORPORATION (JP) | 2018-01-25 | — | — | US | disclosed |
| US-20180022716-A1 | POLYMERIZABLE COMPOUND AND OPTICAL ISOMER | DIC CORPORATION (JP) | 2018-01-25 | — | — | US | disclosed |
| WO-2017079867-A1 | POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY | DIC CORPORATION (JP) | 2017-05-18 | — | — | WO | disclosed |
| CN-105885466-A | Synthesis method of monomethine cyanine dye | 付义乐 | 2016-08-24 | — | — | CN | disclosed |
| US-5738969-A | WATER INSOLUBLE COMPOUND HAVING MERCAPTO OR THIONE GROUP, AND SULFONATED STYRENE-CONTAINING POLYMER | MITSUBISHI PAPER MILLS LIMITED (JP) | 1998-04-14 | — | — | US | disclosed |
| US-5525455-A | IMPROVING INK RECEPTIVITY BY APPLYING SOLUTION CONTAINING COMPOUND HAVING OLEOPHILIC GROUP AND MERCAPTO OR THIONE GROUP, ALKANOLAMINE | MITSUBISHI PAPER MILLS LIMITED (JP) | 1996-06-11 | — | — | US | disclosed |
| EP-0639798-A1 | Treating solution for lithographic printing plate | MITSUBISHI PAPER MILLS, LTD. (JP) | 1995-02-22 | — | — | EP | disclosed |
| US-5391457-A | For silver complex diffusion transfer processing in presence of a triazole, oxadiazole type compound; wear resistance of plates; good ink receptivity; free from waste solution disposal | FUJI PHOTO FILM CO., LTD (JP) | 1995-02-21 | — | — | US | disclosed |
| EP-0282365-B1 | 1-DETHIA-2-THIA-CEPHALOSPORANIC-ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AS THERAPEUTIC AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ROUSSEL-UCLAF (FR) | 1993-05-12 | — | — | EP | disclosed |
| US-5153097-A | LIGHT-SENSITIVE MATERIAL FOR LITHOGRAPHIC PRINTING PLATE AND PROCESS FOR MAKING PRINTING PLATE | MITSUBISHI PAPER MILLS LIMITED (JP) | 1992-10-06 | — | — | US | disclosed |
| US-4908359-A | Pharmaceuticals | Uclaf, Roussel (FR) | 1990-03-13 | — | — | US | disclosed |
| EP-0282365-A1 | 1-Dethia-2-thia-cephalosporanic-acid derivatives, process for their preparation, their use as therapeutic agents and pharmaceutical compositions containing them | ROUSSEL-UCLAF (FR) | 1988-09-14 | — | — | EP | disclosed |
| US-4230792-A | COMPLEXING SILVER WITH THIOL OR THIONE | MITSUBISHI PAPER MILLS, LTD. (JP) | 1980-10-28 | — | — | US | disclosed |
| US-3954474-A | SILVER HALIDE EMULSION; ALDEHYDE TYPE HARDENER | FUJI PHOTO FILM CO., LTD. (JA) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10919870-B2 | Polymerizable compound and optically anisotropic body | ZYX, ZW10, DPY30 | MAPT 545/4885ALDH1A1 2807/4885CA12 2640/4885 |
| US-20180022716-A1 | POLYMERIZABLE COMPOUND AND OPTICAL ISOMER | SMC4, MAP1LC3C, ZW10 | MAPT 27/4885ALDH1A1 3195/4885CA12 2114/4885 |
| US-11046889-B2 | Polymerizable compound and optically anisotropic body | OCIAD1, RCC1, OCIAD2 | MAPT 323/4885ALDH1A1 217/4885CA12 3107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.